Pabau GO app

The new Pabau GO is heredownload on the App Store

Download on the App Store
Book a demo Book a demo
Diagnostic Codes

ICD-10 Code M30.0: Polyarteritis nodosa

Key Takeaways

Key Takeaways

ICD-10 Code M30.0 is the billable diagnosis code for polyarteritis nodosa (PAN), a systemic necrotizing vasculitis affecting medium-sized arteries.

M30.0 is valid for FY2026 submission, effective October 1, 2025, under chapter M00-M99 (diseases of the musculoskeletal system and connective tissue).

Coders must distinguish M30.0 from sibling codes M30.1 (lung involvement), M30.2 (juvenile polyarteritis), and M30.3 (Kawasaki disease) to avoid claim errors.

Pabau’s claims management software and digital forms help rheumatology and specialty practices document PAN accurately and reduce coding-related denials.

ICD-10 Code M30.0: definition, billable status, and effective date

Most vasculitis-related claim denials trace back to one problem: the wrong subcode. ICD-10 Code M30.0 is the billable, specific code for polyarteritis nodosa (PAN), and selecting it correctly requires understanding what the code does and does not cover.

According to the CDC/NCHS ICD-10-CM web tool, M30.0 became effective on October 1, 2025 as part of the 2026 edition of ICD-10-CM. It is classified under chapter M00-M99 (Diseases of the musculoskeletal system and connective tissue), category M30-M36 (Systemic connective tissue disorders). The code is a valid billable/specific code accepted for HIPAA-covered transactions. Pabau’s claims management software helps specialty practices submit M30.0 claims with the supporting documentation payers expect.

Automate claims through Healthcode
Automate claims through Healthcode
Field Details
Code M30.0
Full descriptor Polyarteritis nodosa
Code system ICD-10-CM (US clinical modification)
Chapter M00-M99: Diseases of the musculoskeletal system and connective tissue
Category M30-M36: Systemic connective tissue disorders
Billable/specific Yes – valid for HIPAA-covered claim submission
Effective date October 1, 2025 (FY2026 edition)
Parent category code M30 (Polyarteritis nodosa and related conditions)

Clinical description: what is polyarteritis nodosa?

Polyarteritis nodosa is a systemic necrotizing vasculitis that selectively affects medium-sized muscular arteries. Unlike large-vessel vasculitides such as giant cell arteritis, PAN spares capillaries, venules, and arterioles. The inflammatory process causes vessel wall necrosis, leading to ischemia and infarction in affected organs.

Organs most commonly involved include the kidneys, peripheral nerves, skin, gastrointestinal tract, and muscles. Clinicians in dermatology and rheumatology will encounter PAN most frequently, though internal medicine and nephrology practices also document this condition regularly. Accurate coding starts with recognising the organ systems involved, since these drive the associated diagnosis codes filed alongside M30.0.

Signs and symptoms of polyarteritis nodosa

Clinical documentation for M30.0 should reflect the presenting features that support the diagnosis. Common findings include:

  • Constitutional symptoms: fever, unintentional weight loss, malaise, fatigue
  • Musculoskeletal: myalgia, arthralgia, arthritis
  • Neurological: mononeuritis multiplex (asymmetric sensorimotor neuropathy), central nervous system involvement in rare cases
  • Renal: hypertension, renal insufficiency from renovascular involvement (glomerulonephritis is absent in classic PAN)
  • Cutaneous: livedo reticularis, subcutaneous nodules, skin ulcers, purpura
  • Gastrointestinal: abdominal pain, nausea, intestinal ischemia
  • Testicular: orchitis or testicular pain in male patients

Note that glomerulonephritis is notably absent in classic PAN, which helps distinguish it from ANCA-associated vasculitides coded elsewhere. This distinction matters for accurate code assignment. Review intraparenchymal hemorrhage ICD-10 codes when CNS complications require separate documentation.

ICD-10 Code M30.0 synonyms and index references

The ICD-10-CM alphabetic index lists several terms that map to M30.0. Coders should recognise all of them to avoid assigning incorrect codes when physician documentation uses alternative terminology.

  • Polyarteritis nodosa
  • Polyarteritis (nodosa)
  • Necrotizing arteritis
  • Periarteritis nodosa
  • Panarteritis nodosa
  • Systemic necrotizing vasculitis (medium vessel, non-ANCA)

When a physician documents “periarteritis nodosa” or “panarteritis nodosa,” the correct index lookup still resolves to M30.0. Coding from the clinical description rather than the exact physician term can lead to misassignment, particularly when records arrive from outside specialists using older terminology. The AAPC ICD-10-CM code lookup provides a searchable alphabetic index that confirms these mappings.

ICD-10-CM coding guidelines for M30.0

The CMS ICD-10-CM coding guidelines govern when and how M30.0 is applied. Several rules directly affect claim accuracy for vasculitis diagnoses.

Excludes notes for M30.0

The M30 category carries exclusion notes that restrict or redirect code use. Coders must apply these before submitting M30.0. Understanding them also matters for practices managing HIPAA compliance for medical offices, where incorrect code submission carries audit risk.

Note type Excluded condition Action
Excludes1 Infantile polyarteritis (M30.2) Never code M30.0 and M30.2 together; use M30.2 for juvenile/infantile presentation
Category exclusion ANCA-associated vasculitides (e.g., granulomatosis with polyangiitis, microscopic polyangiitis) These conditions have distinct codes in M31; do not use M30.0
Category exclusion Mucocutaneous lymph node syndrome (Kawasaki disease) Use M30.3 for Kawasaki disease; it is a distinct subcategory of M30

Sequencing guidance: When M30.0 is the reason for an encounter, code it as the principal diagnosis. Manifestation codes for organ involvement (such as renal insufficiency or peripheral neuropathy) follow as additional diagnoses. Do not reverse this sequence unless the encounter is specifically for management of the organ complication rather than the vasculitis itself.

M30 is the parent category for polyarteritis nodosa and related conditions. Selecting the correct subcode is essential because each represents a clinically distinct condition. Practices coding vasculitis regularly should review how similar coding patterns apply across ICD-10-CM categories where specificity requirements are high.

Code Descriptor Key distinguishing feature
M30.0 Polyarteritis nodosa Classic PAN; medium-vessel necrotizing vasculitis; no glomerulonephritis; ANCA-negative
M30.1 Polyarteritis with lung involvement (Churg-Strauss) Eosinophilic granulomatosis with polyangiitis; pulmonary involvement present
M30.2 Juvenile polyarteritis Paediatric presentation; infantile polyarteritis; Excludes1 from M30.0
M30.3 Mucocutaneous lymph node syndrome (Kawasaki) Fever, rash, lymphadenopathy; predominantly affects children; coronary aneurysm risk
M30.8 Other conditions related to polyarteritis nodosa Polyangiitis overlap syndrome; use when documented condition does not fit M30.0-M30.3

The WHO ICD-10 browser provides the international classification context for these codes, which is useful when documenting patients transferred from international health systems where WHO ICD-10 (not ICD-10-CM) was used.

Pro Tip

When documentation states ‘vasculitis NOS’ without specifying vessel size or ANCA status, query the physician before assigning M30.0. PAN requires confirmation of medium-vessel involvement and ANCA-negative status. Assigning M30.0 based on unspecified vasculitis documentation risks payer audit and potential downcoding.

Common associated diagnoses and comorbidities

PAN rarely presents in isolation. Accurate and complete claim submission for M30.0 encounters typically requires additional codes to capture the full clinical picture. The conditions below are commonly coded alongside M30.0 in rheumatology and specialty practice settings.

  • Renal involvement: N26.9 (Renal insufficiency, unspecified) or N28.9 (Disorder of kidney and ureter, unspecified) when renal function is affected by renovascular PAN
  • Peripheral neuropathy: G62.9 (Polyneuropathy, unspecified) or G57- codes for mononeuritis multiplex presentations
  • Hypertension: I10 (Essential primary hypertension) when renovascular involvement drives blood pressure elevation
  • Skin manifestations: L98.0 (Pyogenic granuloma) or L95.0 (Livedoid vasculopathy) for cutaneous PAN features
  • Hepatitis B association: B18.1 (Chronic viral hepatitis B without delta-agent) when HBV-associated PAN is documented; this drives a specific treatment pathway
  • Weight loss: R63.4 (Abnormal weight loss) when constitutional wasting is documented as a separate clinical concern

HBV-associated PAN (hepatitis B-associated) is a clinically distinct subset, and documentation of the underlying hepatitis B infection should always be captured with the appropriate B18- code. Payer scrutiny of vasculitis claims often focuses on whether associated organ manifestations are supported in the record. Practices using structured medical forms at their healthcare practice are better positioned to capture this level of clinical detail at point of care.

Reduce coding errors and claim denials for complex diagnoses

Pabau's integrated claims management and digital documentation tools help rheumatology and specialty practices build accurate records that support M30.0 and associated diagnosis submissions from day one.

Pabau clinic management platform

Documentation tips for accurate M30.0 coding

PAN diagnoses are high-complexity records. Incomplete documentation is the most common reason M30.0 claims face medical necessity denials or requests for additional information. The checklist below supports coders and clinical teams working together to build complete records. Keeping patient records up to date is foundational to avoiding downstream billing issues.

Documentation element Why it matters for M30.0
Explicit diagnosis statement Physician must document “polyarteritis nodosa” or an accepted synonym; “vasculitis” alone is insufficient for M30.0
Vessel size specification Record should confirm medium-vessel involvement to support M30.0 versus small-vessel codes in M31
ANCA test results ANCA-negative status distinguishes PAN from microscopic polyangiitis (M31.7); document lab results in the record
HBV serology HBV-associated PAN requires concurrent B18.1; document HBsAg status when applicable
Organ system involvement List each affected system to support additional ICD-10-CM codes filed alongside M30.0
Diagnostic basis Document whether diagnosis is based on clinical criteria, angiography, or tissue biopsy; payers may request this for complex claims
Age at onset Juvenile onset triggers consideration of M30.2 rather than M30.0; document patient age explicitly

Practices that build these elements into structured intake and clinical note workflows catch documentation gaps before claims are submitted, not after denials arrive. Pabau’s digital intake forms and patient record management tools make it straightforward to build vasculitis-specific documentation templates that prompt clinicians to capture each required data point.

Customizable consent and intake forms
Customizable consent and intake forms

Improving patient compliance with documentation workflows is equally important: when patients complete structured pre-visit forms that capture symptom history, prior diagnoses, and medication records, the clinical note has a richer foundation for the M30.0 documentation requirements above. This also helps practices working across complex diagnostic scenarios, such as those involving ICD-10 coding for complex chronic conditions with multiple comorbidities.

Pro Tip

Flag all M30.0 claims for coder review before submission if the physician note contains only ‘vasculitis’ without further specification. Query the physician using a standard physician query form asking for vessel size, ANCA status, and whether PAN specifically was the intended diagnosis. This single step prevents the majority of M30.0-related medical necessity denials.

Conclusion

Vasculitis coding errors cluster around one failure: assigning M30.0 when the record doesn’t support PAN specifically. Getting it right means confirming medium-vessel involvement, ANCA-negative status, and explicit physician documentation before the claim goes out.

Pabau’s claims management software gives rheumatology and specialty practices a structured environment to build compliant M30.0 records, link supporting diagnosis codes, and track claim outcomes in one place. To see how Pabau supports complex diagnostic coding workflows, book a demo.

Continue your research

Continue your research

Need a structured approach to managing complex chronic condition records? Why you should keep client records up to date covers the practical steps for maintaining accurate, audit-ready patient documentation.

Coding another ICD-10-CM condition with neurological involvement? Intraparenchymal hemorrhage ICD-10 codes provides a parallel reference guide for complex vascular diagnosis coding.

Looking for HIPAA-aligned documentation workflows for your specialty practice? HIPAA compliance for medical offices outlines the documentation and record-keeping requirements that underpin compliant billing.

Frequently Asked Questions

What is ICD-10 Code M30.0?

ICD-10 Code M30.0 is the billable ICD-10-CM diagnosis code for polyarteritis nodosa (PAN), a systemic necrotizing vasculitis affecting medium-sized muscular arteries. It is valid for FY2026 claim submission, effective October 1, 2025, and is classified under chapter M00-M99 (Diseases of the musculoskeletal system and connective tissue).

Is M30.0 a billable ICD-10-CM code?

Yes, M30.0 is a billable, specific ICD-10-CM code valid for HIPAA-covered claim submission. It is a terminal code in the ICD-10-CM hierarchy, meaning it cannot be further subdivided and is accepted directly for diagnosis reporting.

What is the difference between M30.0 and M30.1?

M30.0 covers classic polyarteritis nodosa, which affects medium-sized arteries without lung involvement. M30.1 covers polyarteritis with lung involvement, historically associated with Churg-Strauss syndrome (eosinophilic granulomatosis with polyangiitis). Pulmonary involvement documented in the record is the key differentiator that routes coding to M30.1 rather than M30.0.

What are the subcodes under ICD-10 category M30?

The M30 category includes M30.0 (Polyarteritis nodosa), M30.1 (Polyarteritis with lung involvement), M30.2 (Juvenile polyarteritis), M30.3 (Mucocutaneous lymph node syndrome/Kawasaki disease), and M30.8 (Other conditions related to polyarteritis nodosa). Each represents a clinically distinct condition and must not be used interchangeably.

What are the excludes notes for ICD-10 Code M30.0?

M30.0 carries an Excludes1 note for infantile polyarteritis (M30.2), meaning these two codes cannot be assigned simultaneously. The M30 category also excludes ANCA-associated vasculitides coded in M31 and Kawasaki disease (M30.3), which require their own distinct codes.

How do I document polyarteritis nodosa for ICD-10 coding?

Physician documentation should explicitly state “polyarteritis nodosa” or an accepted synonym, confirm medium-vessel involvement, record ANCA test results (ANCA-negative status supports M30.0), and document each organ system affected. Hepatitis B serology should also be captured when HBV-associated PAN is suspected, as this drives an additional B18.1 code.

×